FDA — authorised 26 February 2018
- Application: ANDA208234
- Marketing authorisation holder: SHANGHAI HENGRUI
- Local brand name: DESFLURANE
- Indication: LIQUID — INHALATION
- Status: approved
FDA authorised Volatile agent on 26 February 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 26 February 2018; FDA has authorised it.
SHANGHAI HENGRUI holds the US marketing authorisation.